Olivia is a successful executive with over 20 years of experience in commercialization, pharmaceutical drug development and healthcare management. As an early member of the team that built the oncology franchise at Genentech Inc., Olivia played a key role in the launch of several of the world’s largest revenue producing oncology drugs, including Rituxan, Herceptin and Avastin.

Currently, Olivia Ware is Senior Vice President of US Market and Franchise Development and Commercial Leader at Proteus Digital Health. Proteus is an innovative company utilizing technology to enable a new category of pharmaceuticals: Digital Medicines. Olivia Ware has been named one of Savoy Magazine’s 2019 Most Influential Women in Corporate America.

Reporting to the CEO and a member of the Executive team, Olivia leads the commercial organization at Proteus. In this role, she is responsible for the company’s commercial strategy, focusing on growth strategies to expand the use of digital medicines.


Current Events
  • Moderator, MedtechVISION 2019Innovation Beyond R&D: Novel Approaches to Commercialization
Note: Speaker biographies were written at time of speaking engagement and may not reflect their current job title and position.
View All
Connect With Olivia